PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	Impact	SUPERFICIAL_RELATIONSHIP	[0]	[6]	BMJ_2008_Nov_7_337_a2001_T97
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	To examine	QUESTION_ANSWERED_BY_THIS_WORK	[214]	[224]	BMJ_2008_Nov_7_337_a2001_T226
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_0	[0]	[450]	['Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation, and perinatal mortality in rural western China: double blind cluster randomised controlled trial\n\nAbstract\nObjective To examine the impact of antenatal supplementation with multiple micronutrients or iron and folic acid compared with folic acid alone on birth weight, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	impact	SUPERFICIAL_RELATIONSHIP	[229]	[235]	BMJ_2008_Nov_7_337_a2001_T98
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_9	[1312]	[1459]	['Iron-folic acid was associated with a significantly reduced risk of early preterm delivery (<34 weeks) (relative risk 0.50, 0.27 to 0.94, P=0.031).']	associated	SUPERFICIAL_RELATIONSHIP	[1332]	[1342]	BMJ_2008_Nov_7_337_a2001_T99
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	but	ANOMALY_CURIOUS_FINDING	[1767]	[1770]	BMJ_2008_Nov_7_337_a2001_T172
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_11	[1683]	[1898]	['In post hoc analyses there were no significant differences for perinatal mortality, but iron-folic acid was associated with a significantly reduced early neonatal mortality by 54% (relative risk 0.46, 0.21 to 0.98).']	associated	SUPERFICIAL_RELATIONSHIP	[1791]	[1801]	BMJ_2008_Nov_7_337_a2001_T100
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_12	[1899]	[2093]	['Conclusion In rural populations in China antenatal supplementation with iron-folic acid was associated with longer gestation and a reduction in early neonatal mortality compared with folic acid.']	associated	SUPERFICIAL_RELATIONSHIP	[1991]	[2001]	BMJ_2008_Nov_7_337_a2001_T101
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	associated	SUPERFICIAL_RELATIONSHIP	[2123]	[2133]	BMJ_2008_Nov_7_337_a2001_T102
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	but	ANOMALY_CURIOUS_FINDING	[2197]	[2200]	BMJ_2008_Nov_7_337_a2001_T173
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_13	[2094]	[2291]	['Multiple micronutrients were associated with modestly increased birth weight compared with folic acid, but, despite this weight gain, there was no significant reduction in early neonatal mortality.']	despite	ANOMALY_CURIOUS_FINDING	[2202]	[2209]	BMJ_2008_Nov_7_337_a2001_T174
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	need	IMPORTANT_CONSIDERATION	[2331]	[2335]	BMJ_2008_Nov_7_337_a2001_T153
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_14	[2292]	[2430]	['Pregnant women in developing countries need sufficient doses of iron in nutrient supplements to maximise reductions in neonatal mortality.']	sufficient	IMPORTANT_CONSIDERATION	[2336]	[2346]	BMJ_2008_Nov_7_337_a2001_T154
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	contribute	SUPERFICIAL_RELATIONSHIP	[2496]	[2506]	BMJ_2008_Nov_7_337_a2001_T103
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	risk	IMPORTANT_CONSIDERATION	[2801]	[2805]	BMJ_2008_Nov_7_337_a2001_T155
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	at risk	IMPORTANT_CONSIDERATION	[2880]	[2887]	BMJ_2008_Nov_7_337_a2001_T156
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	possible	INCOMPLETE_EVIDENCE	[2926]	[2934]	BMJ_2008_Nov_7_337_a2001_T6
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	effects	SUPERFICIAL_RELATIONSHIP	[2953]	[2960]	BMJ_2008_Nov_7_337_a2001_T104
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	major	IMPORTANT_CONSIDERATION	[3018]	[3023]	BMJ_2008_Nov_7_337_a2001_T157
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	poor	IMPORTANT_CONSIDERATION	[3082]	[3086]	BMJ_2008_Nov_7_337_a2001_T158
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	Poor	IMPORTANT_CONSIDERATION	[3226]	[3230]	BMJ_2008_Nov_7_337_a2001_T159
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	requirements	IMPORTANT_CONSIDERATION	[3300]	[3312]	BMJ_2008_Nov_7_337_a2001_T160
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	can	INCOMPLETE_EVIDENCE	[3345]	[3348]	BMJ_2008_Nov_7_337_a2001_T7
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	lead	PROBABLE_UNDERSTANDING	[3349]	[3353]	BMJ_2008_Nov_7_337_a2001_T84
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	contribute	SUPERFICIAL_RELATIONSHIP	[3410]	[3420]	BMJ_2008_Nov_7_337_a2001_T105
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	proposed	INCOMPLETE_EVIDENCE	[3513]	[3521]	BMJ_2008_Nov_7_337_a2001_T8
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_16	[2467]	[3805]	['Introduction\nNeonatal deaths contribute greatly to child mortality in developing countries, and these deaths have steadily increased as a percentage of all deaths of children under the age of 5.12In China, by 2004 neonatal mortality accounted for more than half of all deaths in children under 5.3Low birthweight babies are at higher risk of morbidity and mortality than those of normal birth weight4and are also at risk of postnatal growth retardation, with possible adverse long term effects on their physical and cognitive development.56One of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy, resulting in restricted fetal growth especially during the third trimester.7\nPoor quality diet and inadequate intake, combined with increased nutrient requirements for placental and fetal growth, can lead to multiple micronutrient deficiencies in pregnancy and contribute to higher rates of low birth weight.8To address these multiple deficiency states Unicef has proposed the use of multiple micronutrient supplements in pregnancy that provide the recommended individual intakes for pregnant women.9\nChina is the most populated developing country in the world, and the prevalence of low birth weight varies across different socioeconomic groups and areas.']	recommended	FUTURE_WORK	[3598]	[3609]	BMJ_2008_Nov_7_337_a2001_T150
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_17	[3806]	[4091]	['A 1999 survey of low birth weight in China showed a prevalence of low birth weight of 7.6% and 11.8% in “poor” and “very poor” counties, respectively.10With an average prevalence of low birth weight of 5.9%, an estimated 1.2 million low birthweight babies are born in China every year.']	showed	INCOMPLETE_EVIDENCE	[3849]	[3855]	BMJ_2008_Nov_7_337_a2001_T9
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_17	[3806]	[4091]	['A 1999 survey of low birth weight in China showed a prevalence of low birth weight of 7.6% and 11.8% in “poor” and “very poor” counties, respectively.10With an average prevalence of low birth weight of 5.9%, an estimated 1.2 million low birthweight babies are born in China every year.']	estimated	INCOMPLETE_EVIDENCE	[4017]	[4026]	BMJ_2008_Nov_7_337_a2001_T10
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	no ... policies	FULL_UNKNOWN	[4234, 4246]	[4236, 4254]	BMJ_2008_Nov_7_337_a2001_T0
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_18	[4092]	[4393]	['The only antenatal supplement promoted by the Ministry of Health in China is folic acid to prevent congenital neural tube defects.11There are no specific policies or programmes for the distribution of multiple micronutrient or iron-folic acid supplements during pregnancy, even to disadvantaged women.']	even	ANOMALY_CURIOUS_FINDING	[4365]	[4369]	BMJ_2008_Nov_7_337_a2001_T175
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_19	[4394]	[4601]	['To provide evidence in China to formulate public health policy on nutrient supplementation in pregnancy we conducted a community based cluster randomised controlled trial in a disadvantaged rural population.']	conducted	QUESTION_ANSWERED_BY_THIS_WORK	[4501]	[4510]	BMJ_2008_Nov_7_337_a2001_T227
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	assessed	QUESTION_ANSWERED_BY_THIS_WORK	[4605]	[4613]	BMJ_2008_Nov_7_337_a2001_T228
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_20	[4602]	[4842]	['We assessed the impact of iron-folic acid and multiple micronutrient supplements during pregnancy, compared with folic acid alone, on birth anthropometry, duration of gestation, and maternal haemoglobin concentration in the third trimester.']	impact	SUPERFICIAL_RELATIONSHIP	[4618]	[4624]	BMJ_2008_Nov_7_337_a2001_T106
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	conducted	QUESTION_ANSWERED_BY_THIS_WORK	[4851]	[4860]	BMJ_2008_Nov_7_337_a2001_T229
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_21	[4843]	[4989]	['We also conducted a post hoc assessment of the impact of the supplements on perinatal mortality, comprising stillbirths and early neonatal deaths.']	impact	SUPERFICIAL_RELATIONSHIP	[4890]	[4896]	BMJ_2008_Nov_7_337_a2001_T107
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	study	INCOMPLETE_EVIDENCE	[5117]	[5122]	BMJ_2008_Nov_7_337_a2001_T11
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_23	[5109]	[5229]	['A pilot study found a low birth rate of 13% and 57% of women with anaemia (haemoglobin <110 g/l) in the third trimester.']	found	INCOMPLETE_EVIDENCE	[5123]	[5128]	BMJ_2008_Nov_7_337_a2001_T12
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_29	[5916]	[6047]	['The treatment codes were opened only once all data had been collected and blinded analysis of the primary hypothesis was completed.']	only	INCOMPLETE_EVIDENCE	[5948]	[5952]	BMJ_2008_Nov_7_337_a2001_T13
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	estimated	INCOMPLETE_EVIDENCE	[6294]	[6303]	BMJ_2008_Nov_7_337_a2001_T14
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_31	[6260]	[6698]	['Before the start of the trial, we estimated that we needed a sample of 2255 eligible pregnant women per treatment to detect a 25% reduction in low birth weight between either iron-folic acid or multiple micronutrient and folic acid (control) groups, assuming a two tailed test, with α=0.05 and β=0.20, and a prevalence of low birth weight of 9.3% (based on a three month sample in 2000 of births from a county hospital in the study area).']	assuming	ALTERNATIVE_OPTIONS_CONTROVERSY	[6510]	[6518]	BMJ_2008_Nov_7_337_a2001_T201
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_32	[6699]	[6813]	['We increased the sample size to 2480 pregnant women per group to account for 10% fetal loss and loss to follow-up.']	account for	PROBABLE_UNDERSTANDING	[6764]	[6775]	BMJ_2008_Nov_7_337_a2001_T85
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	however	ANOMALY_CURIOUS_FINDING	[7004]	[7011]	BMJ_2008_Nov_7_337_a2001_T176
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	however	ALTERNATIVE_OPTIONS_CONTROVERSY	[7004]	[7011]	BMJ_2008_Nov_7_337_a2001_T202
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	because	PROBLEM_COMPLICATION	[7013]	[7020]	BMJ_2008_Nov_7_337_a2001_T221
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_34	[6966]	[7163]	['Recruitment was slower than expected, however, because many births were in women who lived in large cities in eastern China but who returned to their village to give birth and register their child.']	because	PROBABLE_UNDERSTANDING	[7013]	[7020]	BMJ_2008_Nov_7_337_a2001_T86
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_35	[7164]	[7272]	['After 3.5 years the trial sponsor requested that recruitment be stopped because of limitations with funding.']	because	PROBLEM_COMPLICATION	[7236]	[7243]	BMJ_2008_Nov_7_337_a2001_T222
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	estimated	INCOMPLETE_EVIDENCE	[7358]	[7367]	BMJ_2008_Nov_7_337_a2001_T15
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_37	[7355]	[7723]	['We estimated that this sample of about 1900 women per treatment would provide 80% power to detect a 50 g difference in birth weight between either iron-folic acid or multiple micronutrients and folic acid (control) groups, assuming a two tailed test, with α=0.05 and birth weight standard deviation (SD) of 436 g (based on values observed across all treatment groups).']	assuming	ALTERNATIVE_OPTIONS_CONTROVERSY	[7578]	[7586]	BMJ_2008_Nov_7_337_a2001_T203
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_38	[7724]	[7977]	['This sample size, however, only had 80% power to detect a 40% reduction in low birth weight between treatment groups, assuming a two tailed test, with α=0.05 and a prevalence of low birth weight of 4.6% (prevalence observed across all treatment groups).']	however	ALTERNATIVE_OPTIONS_CONTROVERSY	[7742]	[7749]	BMJ_2008_Nov_7_337_a2001_T204
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_38	[7724]	[7977]	['This sample size, however, only had 80% power to detect a 40% reduction in low birth weight between treatment groups, assuming a two tailed test, with α=0.05 and a prevalence of low birth weight of 4.6% (prevalence observed across all treatment groups).']	only	INCOMPLETE_EVIDENCE	[7751]	[7755]	BMJ_2008_Nov_7_337_a2001_T16
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_38	[7724]	[7977]	['This sample size, however, only had 80% power to detect a 40% reduction in low birth weight between treatment groups, assuming a two tailed test, with α=0.05 and a prevalence of low birth weight of 4.6% (prevalence observed across all treatment groups).']	assuming	ALTERNATIVE_OPTIONS_CONTROVERSY	[7842]	[7850]	BMJ_2008_Nov_7_337_a2001_T205
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_39	[7978]	[8203]	['It also had a similarly low power of 80% to detect a 50% reduction in early neonatal mortality between treatment groups, assuming a two tailed test, with α=0.05 and an early neonatal mortality rate of 15 per 1000 live births.']	assuming	ALTERNATIVE_OPTIONS_CONTROVERSY	[8099]	[8107]	BMJ_2008_Nov_7_337_a2001_T206
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_42	[8517]	[8784]	['At the start the village doctor conducted a mini-survey of all women of reproductive age living in their village to identify those who were likely to become pregnant, including newly married women, those not using contraception, or those who said they wanted a child.']	likely	PROBABLE_UNDERSTANDING	[8657]	[8663]	BMJ_2008_Nov_7_337_a2001_T87
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_47	[9474]	[9626]	['Newly identified pregnant women were interviewed to record their sociodemographic status and their menstrual, reproductive, medical, and family history.']	Newly identified	FULL_UNKNOWN	[9474]	[9490]	BMJ_2008_Nov_7_337_a2001_T1
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_52	[10337]	[10943]	['The multiple micronutrient supplements were formulated to contain approximately the WHO/Unicef recommended dietary allowances for each of 15 minerals or vitamins as follows: 30 mg iron, 400 µg folate, 15.0 mg zinc, 2.0 mg copper, 65.0 µg selenium, 150.0 µg iodine, 800.0 µg vitamin A, 1.4 mg vitamin B-1 (thiamine), 1.4 mg vitamin B-2 (riboflavin), 1.9 mg vitamin B-6, 2.6 µg vitamin B-12, 5.0 µg vitamin D, 70.0 mg vitamin C, 10.0 mg vitamin E, and 18.0 mg niacin.12Iron-folic acid supplements contained 60 mg iron (twice the amount of elemental iron in the multiple micronutrients) and 400 µg folic acid.']	recommended	FUTURE_WORK	[10432]	[10443]	BMJ_2008_Nov_7_337_a2001_T151
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_60	[12290]	[12380]	['We excluded from analyses newborn anthropometry collected later than 72 hours after birth.']	excluded	INCOMPLETE_EVIDENCE	[12293]	[12301]	BMJ_2008_Nov_7_337_a2001_T17
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_67	[13525]	[13708]	['We excluded haemoglobin measurements collected before 6 July 2004 because in winter these measurements were taken below the operating range, potentially resulting in incorrect values.']	excluded	INCOMPLETE_EVIDENCE	[13528]	[13536]	BMJ_2008_Nov_7_337_a2001_T18
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_67	[13525]	[13708]	['We excluded haemoglobin measurements collected before 6 July 2004 because in winter these measurements were taken below the operating range, potentially resulting in incorrect values.']	potentially	INCOMPLETE_EVIDENCE	[13666]	[13677]	BMJ_2008_Nov_7_337_a2001_T19
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_67	[13525]	[13708]	['We excluded haemoglobin measurements collected before 6 July 2004 because in winter these measurements were taken below the operating range, potentially resulting in incorrect values.']	incorrect	PROBLEM_COMPLICATION	[13691]	[13700]	BMJ_2008_Nov_7_337_a2001_T223
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_73	[14636]	[14817]	['Statistical analysis\nTo assess the effectiveness of randomisation we examined the baseline characteristics of the clusters and the individual pregnant women across treatment groups.']	To assess	QUESTION_ANSWERED_BY_THIS_WORK	[14657]	[14666]	BMJ_2008_Nov_7_337_a2001_T230
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_73	[14636]	[14817]	['Statistical analysis\nTo assess the effectiveness of randomisation we examined the baseline characteristics of the clusters and the individual pregnant women across treatment groups.']	examined	QUESTION_ANSWERED_BY_THIS_WORK	[14705]	[14713]	BMJ_2008_Nov_7_337_a2001_T231
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_74	[14818]	[15063]	['A wealth index was constructed from an inventory of 16 household assets or facilities with a principal component analysis method,15and this index was categorised into thirds as an indicator for the poorest, middle income, and richest households.']	indicator	SUPERFICIAL_RELATIONSHIP	[14998]	[15007]	BMJ_2008_Nov_7_337_a2001_T108
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_75	[15064]	[15206]	['The mean number of supplements consumed and treatment compliance rates (percentage of days that supplements were consumed) were also examined.']	examined	QUESTION_ANSWERED_BY_THIS_WORK	[15197]	[15205]	BMJ_2008_Nov_7_337_a2001_T232
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_81	[16598]	[16740]	['We analysed perinatal mortality only in singleton births to prevent bias from the effect of multiple births, which have higher mortality risk.']	only	INCOMPLETE_EVIDENCE	[16630]	[16634]	BMJ_2008_Nov_7_337_a2001_T20
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_81	[16598]	[16740]	['We analysed perinatal mortality only in singleton births to prevent bias from the effect of multiple births, which have higher mortality risk.']	effect	SUPERFICIAL_RELATIONSHIP	[16680]	[16686]	BMJ_2008_Nov_7_337_a2001_T109
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_93	[18462]	[18534]	['There were 167 stillbirths, where birth weight was not usually recorded.']	not usually	INCOMPLETE_EVIDENCE	[18513]	[18524]	BMJ_2008_Nov_7_337_a2001_T21
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_98	[19052]	[19686]	['Caption (FIG)\n\nFig 1 Participant flow chart\nThe sociodemographic characteristics and the anthropometric measurements at enrolment and the cluster and individual level baseline characteristics were balanced by treatment groups (table 1).The reproductive history of the pregnant women was similar across groups and reflected China’s “one child policy,” with 3585 (61.5%) women having their first pregnancy (table 2).The percentage of women delivering at home was balanced across treatment groups with 9.4% (149) for iron-folic acid group, 12.4% (193) for the multiple micronutrients group, and 11.4% (195) for the folic acid only group.']	similar	SUPERFICIAL_RELATIONSHIP	[19339]	[19346]	BMJ_2008_Nov_7_337_a2001_T110
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_103	[21379]	[22380]	['Figures are numbers (percentages) unless stated otherwiseFolic acidIron-folic acidMultiple micronutrientsNo of pregnant women201719121899Mean (SD) No of pregnancies1.6 (0.7)1.6 (0.7)1.6 (0.7)Parity:\u200301223 (60.6)1184 (61.9)1178 (62.0)\u20031714 (35.4)669 (35.0)657 (34.6)\u2003≥280 (4.0)59 (3.1)64 (3.4)Gestation (weeks):\u2003Mean (SD)13.8 (5.8)13.6 (5.6)13.9 (5.6)\u2003<12884 (43.8)835 (43.7)820 (43.2)\u200312-15432 (21.4)424 (22.2)424 (22.3)\u200316-28701 (34.8)653 (34.2)655 (34.5)Height (cm):\u2003No of women199818971878\u2003Mean (SD)158.8 (5.1)158.9 (5.2)158.7 (5.3)Weight (kg):\u2003No of women197018641846\u2003Mean (SD)52.5 (6.0)52.7 (6.4)52.7 (6.1)BMI (kg/m2):\u2003No of women196818631840\u2003Mean (SD)20.8 (2.2)20.9 (2.3)20.9 (2.2)Mid-upper arm circumference (cm):\u2003No of women198318841872\u2003Mean (SD)23.1 (2.1)23.2 (2.2)23.2 (2.1)\nThere was a high level of compliance with the supplementation in all treatment groups (table 3).The mean number of doses of supplements consumed per women during pregnancy was 165, and this was similar in each group.']	similar	SUPERFICIAL_RELATIONSHIP	[22358]	[22365]	BMJ_2008_Nov_7_337_a2001_T111
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	observed	INCOMPLETE_EVIDENCE	[23658]	[23666]	BMJ_2008_Nov_7_337_a2001_T22
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_107	[23394]	[23877]	['There was no evidence of an effect of iron-folic acid on mean birth weight (P=0.17) but birth weight was significantly higher (42 g, 7 to 78 g, P=0.019) in the multiple micronutrients group compared with the folic acid alone (table 4).The increase in birth weight observed in the iron-folic acid and the multiple micronutrient groups corresponded with reductions in the risk of low birth weight (<2500 g) compared with folic acid alone of 19% (P=0.20) and 22% (P=0.14), respectively.']	corresponded	SUPERFICIAL_RELATIONSHIP	[23728]	[23740]	BMJ_2008_Nov_7_337_a2001_T112
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_108	[23878]	[24127]	['In a post-hoc analysis of babies who were small for gestational age, there were no significant differences in the proportion across the three treatment groups, although the proportion in the multiple micronutrient group was slightly lower (table 4).']	although	ANOMALY_CURIOUS_FINDING	[24038]	[24046]	BMJ_2008_Nov_7_337_a2001_T177
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	observed	INCOMPLETE_EVIDENCE	[27228]	[27236]	BMJ_2008_Nov_7_337_a2001_T23
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_117	[27149]	[27458]	['Compared with folic acid alone, the increase in the mean duration of gestation observed in the multiple micronutrient group corresponded with non-significant reductions in the risk of preterm delivery (<37 weeks) and early preterm delivery (<34 weeks) of 14% (P=0.29) and 30% (P=0.26), respectively (table 4).']	corresponded	SUPERFICIAL_RELATIONSHIP	[27273]	[27285]	BMJ_2008_Nov_7_337_a2001_T113
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_119	[27597]	[27760]	['Table 4 shows that in the iron-folic acid group there was a significant increase in birth length (0.24 cm; 0.02 to 0.46 cm, P=0.03) compared with folic acid alone.']	shows	INCOMPLETE_EVIDENCE	[27605]	[27610]	BMJ_2008_Nov_7_337_a2001_T24
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	indicating	INCOMPLETE_EVIDENCE	[28215]	[28225]	BMJ_2008_Nov_7_337_a2001_T25
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_121	[27987]	[28425]	['Compared with folic acid alone, the difference in mean birth weight, adjusted for multiple births, gestation at delivery, and cluster randomisation, was 12.6 g for the iron-folic acid and 31.0 g for the multiple micronutrients, indicating that the extension of the duration of gestation contributed to a similar increment in mean birth weight for iron-folic acid (11.7 g) and multiple micronutrients (11.3 g) compared with the folic acid.']	contributed to	SUPERFICIAL_RELATIONSHIP	[28274]	[28288]	BMJ_2008_Nov_7_337_a2001_T114
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	however	ANOMALY_CURIOUS_FINDING	[29267]	[29274]	BMJ_2008_Nov_7_337_a2001_T178
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_126	[29200]	[29355]	['In both the iron-folic acid and the multiple micronutrient groups, however, more than 40% of the women were still anaemic in the third trimester (table 4).']	however	ALTERNATIVE_OPTIONS_CONTROVERSY	[29267]	[29274]	BMJ_2008_Nov_7_337_a2001_T207
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_127	[29357]	[29652]	['Impact of supplementation on perinatal mortality\nPost hoc analyses showed no significant impact on the risk of perinatal mortality (stillbirths and early neonatal mortality) either in the iron-folic acid (P=0.307) or in multiple micronutrients group (P=0.336) compared with folic acid (table 5).']	showed	INCOMPLETE_EVIDENCE	[29424]	[29430]	BMJ_2008_Nov_7_337_a2001_T26
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_128	[29654]	[30422]	['Caption (TABLE-WRAP): TABLE 5\n\n\u2002Mortality outcomes (in singleton births)Folic acidIron-folic acidMultiple micronutrientsRelative risk (95% confidence interval)*No in groupRate/1000No in groupRate/1000No in groupRate/1000Iron-folic acid v folic acidMultiple micronutrients v folic acidPregnancies with single live or stillbirth:\u2003Total1688—1546—1532———\u2003Stillbirths (≥ 28 weeks)5230.84730.46341.11.01 (0.67 to 1.51)1.39 (0.95 to 2.04)\u2003Live births1636—1499—1469———All neonatal deaths3320.21610.71812.30.53 (0.29 to 0.97)0.61 (0.34 to 1.10)Early neonatal deaths2414.7106.71510.20.46 (0.21 to 0.98)0.71 (0.36 to 1.39)Perinatal deaths7645.05736.97850.90.84 (0.59 to 1.19)1.18 (0.85 to 1.63)\n*Adjusted for cluster randomisation with general estimating equation binomial model.']	model	INCOMPLETE_EVIDENCE	[30416]	[30421]	BMJ_2008_Nov_7_337_a2001_T27
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	showed	INCOMPLETE_EVIDENCE	[30446]	[30452]	BMJ_2008_Nov_7_337_a2001_T28
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_129	[30423]	[30654]	['Post hoc analyses also showed no effect of iron-folic acid compared with folic acid on the stillbirth rate, though there was a non-significant increase of 39% (relative risk 1.39, 0.95 to 2.04) in the multiple micronutrients group.']	though	ANOMALY_CURIOUS_FINDING	[30531]	[30537]	BMJ_2008_Nov_7_337_a2001_T179
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	indicating	INCOMPLETE_EVIDENCE	[30859]	[30869]	BMJ_2008_Nov_7_337_a2001_T29
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_130	[30655]	[31058]	['When we combined all fetal losses (spontaneous abortions and stillbirths), the rates were 103.1/1000 pregnancies for folic acid, 93.7/1000 for iron-folic acid, and 111.3/1000 for multiple micronutrients, indicating no evidence of an altered risk for total fetal losses with iron-folic acid (relative risk 0.91, 0.74 to 1.12) or with multiple micronutrients (1.15, 0.94 to 1.40) compared with folic acid.']	no evidence	INCOMPLETE_EVIDENCE	[30870]	[30881]	BMJ_2008_Nov_7_337_a2001_T30
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	showed	INCOMPLETE_EVIDENCE	[31081]	[31087]	BMJ_2008_Nov_7_337_a2001_T31
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_131	[31059]	[31265]	['The post hoc analyses showed a reduction in the risk of early neonatal mortality among infants born to women randomised to receive either iron-folic acid or multiple micronutrients compared with folic acid.']	compared with	ALTERNATIVE_OPTIONS_CONTROVERSY	[31240]	[31253]	BMJ_2008_Nov_7_337_a2001_T208
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_132	[31266]	[31481]	['The magnitude of the reduction (54%) was significant for the iron-folic acid group (relative risk 0.46, 0.21 to 0.98) compared with folic acid but not for the multiple micronutrients group (29%; 0.71, 0.36 to 1.39).']	but not	ANOMALY_CURIOUS_FINDING	[31409]	[31416]	BMJ_2008_Nov_7_337_a2001_T180
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_139	[32510]	[32721]	['The highest number of neonatal deaths because of preterm delivery was in the folic acid group (11/73, 15.1%) with similar numbers for iron-folic acid (5/73, 6.8%) and multiple micronutrients (6/73, 8.2%) groups.']	similar	SUPERFICIAL_RELATIONSHIP	[32624]	[32631]	BMJ_2008_Nov_7_337_a2001_T115
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	On the basis	INCOMPLETE_EVIDENCE	[33125]	[33137]	BMJ_2008_Nov_7_337_a2001_T32
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_142	[33125]	[33538]	['On the basis of our results, the number of women who would need to be treated with iron-folic acid from early in pregnancy would be 6.2 (6.1 to 6.3) to prevent one case of maternal anaemia in the third trimester, 83.3 (83.28 to 83.32) to prevent one preterm delivery <37 weeks, 122 (121.99 to 122.01) to prevent one early preterm delivery <34 weeks, and 125 (124.99 to 125.01) to prevent one early neonatal death.']	need	IMPORTANT_CONSIDERATION	[33184]	[33188]	BMJ_2008_Nov_7_337_a2001_T161
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	alone	ANOMALY_CURIOUS_FINDING	[33840]	[33845]	BMJ_2008_Nov_7_337_a2001_T181
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	associated	SUPERFICIAL_RELATIONSHIP	[33901]	[33911]	BMJ_2008_Nov_7_337_a2001_T116
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_145	[33815]	[33989]	['Compared with folic acid alone, multiple micronutrient supplements were significantly associated with increased birth weight, while iron-folic acid had no significant effect.']	while	ANOMALY_CURIOUS_FINDING	[33941]	[33946]	BMJ_2008_Nov_7_337_a2001_T182
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_146	[33990]	[34076]	['Iron-folic acid supplements were significantly associated with increased birth length.']	associated	SUPERFICIAL_RELATIONSHIP	[34037]	[34047]	BMJ_2008_Nov_7_337_a2001_T117
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	but	ANOMALY_CURIOUS_FINDING	[34529]	[34532]	BMJ_2008_Nov_7_337_a2001_T183
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_148	[34233]	[34571]	['In post hoc analyses, the iron-folic acid and the multiple micronutrient supplements had no significant effect on perinatal mortality, but there was a significant 54% reduction in early neonatal mortality in women who received supplementation with iron-folic acid compared with folic acid alone, but no significant effects on stillbirths.']	effects	SUPERFICIAL_RELATIONSHIP	[34548]	[34555]	BMJ_2008_Nov_7_337_a2001_T118
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	associated	SUPERFICIAL_RELATIONSHIP	[34626]	[34636]	BMJ_2008_Nov_7_337_a2001_T119
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_149	[34572]	[34817]	['Both multiple micronutrients and iron-folic acid were associated with significantly increased maternal haemoglobin concentration in the third trimester compared with folic acid, although nearly half of the women in these groups remained anaemic.']	although	ANOMALY_CURIOUS_FINDING	[34750]	[34758]	BMJ_2008_Nov_7_337_a2001_T184
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	have shown	INCOMPLETE_EVIDENCE	[34830]	[34840]	BMJ_2008_Nov_7_337_a2001_T33
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_150	[34818]	[35067]	['Overall, we have shown that antenatal nutrient supplementation is associated with increased maternal haemoglobin concentration in late pregnancy, mean birth weight, and duration of pregnancy and reduced preterm delivery and early neonatal mortality.']	associated	SUPERFICIAL_RELATIONSHIP	[34884]	[34894]	BMJ_2008_Nov_7_337_a2001_T120
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	effects	SUPERFICIAL_RELATIONSHIP	[35072]	[35079]	BMJ_2008_Nov_7_337_a2001_T121
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	seem to be	ANOMALY_CURIOUS_FINDING	[35179]	[35189]	BMJ_2008_Nov_7_337_a2001_T185
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_151	[35068]	[35231]	['The effects of iron-folic acid and multiple micronutrients on the duration of gestation and neonatal mortality seem to be related to the iron in these supplements.']	related	SUPERFICIAL_RELATIONSHIP	[35190]	[35197]	BMJ_2008_Nov_7_337_a2001_T122
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	impact	SUPERFICIAL_RELATIONSHIP	[35246]	[35252]	BMJ_2008_Nov_7_337_a2001_T123
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_152	[35232]	[35398]	['We tested the impact of two different doses of iron in pregnancy—namely, 60 mg in the iron-folic acid supplements and 30 mg in the multiple micronutrient supplements.']	different	ALTERNATIVE_OPTIONS_CONTROVERSY	[35260]	[35269]	BMJ_2008_Nov_7_337_a2001_T209
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	impact	SUPERFICIAL_RELATIONSHIP	[35411]	[35417]	BMJ_2008_Nov_7_337_a2001_T124
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	similar	SUPERFICIAL_RELATIONSHIP	[35508]	[35515]	BMJ_2008_Nov_7_337_a2001_T125
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	pattern	SUPERFICIAL_RELATIONSHIP	[35516]	[35523]	BMJ_2008_Nov_7_337_a2001_T126
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_153	[35399]	[35582]	['The largest impact on neonatal mortality was with the supplement with the highest dose of iron, and we saw a similar pattern for duration of gestation and effects on preterm delivery.']	effects	SUPERFICIAL_RELATIONSHIP	[35554]	[35561]	BMJ_2008_Nov_7_337_a2001_T127
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	In contrast	ALTERNATIVE_OPTIONS_CONTROVERSY	[35583]	[35594]	BMJ_2008_Nov_7_337_a2001_T210
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	recently	INCOMPLETE_EVIDENCE	[35598]	[35606]	BMJ_2008_Nov_7_337_a2001_T34
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	found	INCOMPLETE_EVIDENCE	[35665]	[35670]	BMJ_2008_Nov_7_337_a2001_T35
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	findings	INCOMPLETE_EVIDENCE	[35904]	[35912]	BMJ_2008_Nov_7_337_a2001_T36
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	suggest	INCOMPLETE_EVIDENCE	[35928]	[35935]	BMJ_2008_Nov_7_337_a2001_T37
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	observed	INCOMPLETE_EVIDENCE	[35979]	[35987]	BMJ_2008_Nov_7_337_a2001_T38
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	explained	PROBABLE_UNDERSTANDING	[36066]	[36075]	BMJ_2008_Nov_7_337_a2001_T88
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	but	ALTERNATIVE_OPTIONS_CONTROVERSY	[36109]	[36112]	BMJ_2008_Nov_7_337_a2001_T211
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_154	[35583]	[36162]	['In contrast, a recently reported large scale community based trial from Indonesia found no significant differences for neonatal mortality between daily antenatal supplements with iron-folic acid and multiple micronutrients (WHO/Unicef formulation as tested in China), which both had the same dose of iron (30 mg).18These findings from Indonesia suggest that the higher neonatal mortality rate we observed in China with multiple micronutrients compared with iron-folic acid cannot be explained by the additional micronutrients but by the different dose of iron in the supplements.']	different	ALTERNATIVE_OPTIONS_CONTROVERSY	[36120]	[36129]	BMJ_2008_Nov_7_337_a2001_T212
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	associated	SUPERFICIAL_RELATIONSHIP	[36221]	[36231]	BMJ_2008_Nov_7_337_a2001_T128
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_155	[36163]	[36379]	['In our trial, the multiple micronutrient supplements were associated with a significant increase in birth weight compared with folic acid, but this did not translate into significant reductions in neonatal mortality.']	not	INCOMPLETE_EVIDENCE	[36315]	[36318]	BMJ_2008_Nov_7_337_a2001_T39
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	Rather	ALTERNATIVE_OPTIONS_CONTROVERSY	[36380]	[36386]	BMJ_2008_Nov_7_337_a2001_T213
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	seemed to be	ANOMALY_CURIOUS_FINDING	[36423]	[36435]	BMJ_2008_Nov_7_337_a2001_T186
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_156	[36380]	[36579]	['Rather the reduction in neonatal mortality seemed to be related to the increased duration of gestation and the reduced number of early preterm deliveries because of iron in the antenatal supplements.']	related	SUPERFICIAL_RELATIONSHIP	[36436]	[36443]	BMJ_2008_Nov_7_337_a2001_T129
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	important	IMPORTANT_CONSIDERATION	[36595]	[36604]	BMJ_2008_Nov_7_337_a2001_T162
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	role	SUPERFICIAL_RELATIONSHIP	[36605]	[36609]	BMJ_2008_Nov_7_337_a2001_T130
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	has been	INCOMPLETE_EVIDENCE	[36669]	[36677]	BMJ_2008_Nov_7_337_a2001_T40
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	reported	INCOMPLETE_EVIDENCE	[36678]	[36686]	BMJ_2008_Nov_7_337_a2001_T41
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	19In	INCOMPLETE_EVIDENCE	[36710]	[36714]	BMJ_2008_Nov_7_337_a2001_T42
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_157	[36580]	[36875]	['Evidence of an important role of antenatal iron supplements in reducing preterm delivery has been reported from the United States.19In the US trial, antenatal iron (30 mg), was associated with a reduced rate of preterm delivery (8% v 14%, P=0.05) and increased mean birth weight (108 g, P=0.03).']	associated	SUPERFICIAL_RELATIONSHIP	[36757]	[36767]	BMJ_2008_Nov_7_337_a2001_T131
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_158	[36876]	[37057]	['Longitudinal studies in Brazil20and Bangladesh4indicate that preterm infants have much higher neonatal mortality than babies with retarded intrauterine growth or those born at term.']	Bangladesh4indicate	INCOMPLETE_EVIDENCE	[36912]	[36931]	BMJ_2008_Nov_7_337_a2001_T43
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	reported	INCOMPLETE_EVIDENCE	[37129]	[37137]	BMJ_2008_Nov_7_337_a2001_T44
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	related	SUPERFICIAL_RELATIONSHIP	[37175]	[37182]	BMJ_2008_Nov_7_337_a2001_T132
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	plausible	INCOMPLETE_EVIDENCE	[37243]	[37252]	BMJ_2008_Nov_7_337_a2001_T45
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	reason	PROBABLE_UNDERSTANDING	[37253]	[37259]	BMJ_2008_Nov_7_337_a2001_T89
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	why	EXPLICIT_QUESTION	[37266]	[37269]	BMJ_2008_Nov_7_337_a2001_T3
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	could be	INCOMPLETE_EVIDENCE	[37388]	[37396]	BMJ_2008_Nov_7_337_a2001_T46
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_159	[37058]	[37448]	['In Bangladesh, a study of birth outcomes among low birthweight infants reported that 75% of the neonatal deaths were related to preterm delivery.4These observational findings suggest a plausible reason as to why the increased mean duration of gestation and reduced preterm delivery (especially early preterm delivery) we observed could be related to a large reduction in neonatal mortality.']	related	SUPERFICIAL_RELATIONSHIP	[37397]	[37404]	BMJ_2008_Nov_7_337_a2001_T133
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_161	[37624]	[37810]	['Even though randomisation was by village clusters, there were a large number of clusters (531) with about 180 per treatment group and a relatively small number of births in each cluster.']	Even	ANOMALY_CURIOUS_FINDING	[37624]	[37628]	BMJ_2008_Nov_7_337_a2001_T187
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_161	[37624]	[37810]	['Even though randomisation was by village clusters, there were a large number of clusters (531) with about 180 per treatment group and a relatively small number of births in each cluster.']	though	ANOMALY_CURIOUS_FINDING	[37629]	[37635]	BMJ_2008_Nov_7_337_a2001_T188
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_161	[37624]	[37810]	['Even though randomisation was by village clusters, there were a large number of clusters (531) with about 180 per treatment group and a relatively small number of births in each cluster.']	small	INCOMPLETE_EVIDENCE	[37771]	[37776]	BMJ_2008_Nov_7_337_a2001_T47
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_164	[38119]	[38355]	['The location of the study in a socioeconomically disadvantaged area of western China allowed us to examine effects of nutrient supplements in a population with the highest rates of low birth weight and neonatal mortality in the country.']	to examine	QUESTION_ANSWERED_BY_THIS_WORK	[38215]	[38225]	BMJ_2008_Nov_7_337_a2001_T233
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_164	[38119]	[38355]	['The location of the study in a socioeconomically disadvantaged area of western China allowed us to examine effects of nutrient supplements in a population with the highest rates of low birth weight and neonatal mortality in the country.']	effects	SUPERFICIAL_RELATIONSHIP	[38226]	[38233]	BMJ_2008_Nov_7_337_a2001_T134
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	similar to	INCOMPLETE_EVIDENCE	[38626]	[38636]	BMJ_2008_Nov_7_337_a2001_T48
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	reported	INCOMPLETE_EVIDENCE	[38643]	[38651]	BMJ_2008_Nov_7_337_a2001_T49
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	but	ALTERNATIVE_OPTIONS_CONTROVERSY	[38893]	[38896]	BMJ_2008_Nov_7_337_a2001_T214
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	limitation	INCOMPLETE_EVIDENCE	[38901]	[38911]	BMJ_2008_Nov_7_337_a2001_T50
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	low	PROBLEM_COMPLICATION	[38920]	[38923]	BMJ_2008_Nov_7_337_a2001_T224
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_166	[38485]	[39029]	['There was no evidence of under-enumeration of neonatal deaths, with neonatal mortality rates in the folic acid group (20.2/1000 live births) similar to those reported for equivalent rural counties from the national maternal and child health surveillance system (22.5/1000 live births).3\nThe trial was adequately powered to detect small changes in infant anthropometry at birth and the duration of gestation, but one limitation was the low power to detect changes in the prevalence of low birth weight, preterm delivery, and perinatal mortality.']	low	INCOMPLETE_EVIDENCE	[38920]	[38923]	BMJ_2008_Nov_7_337_a2001_T51
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_167	[39030]	[39203]	['The mortality analyses were post hoc rather than a primary hypothesis and we did not have enough data to fully examine the effects of the different supplements on mortality.']	rather	ALTERNATIVE_OPTIONS_CONTROVERSY	[39067]	[39073]	BMJ_2008_Nov_7_337_a2001_T215
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_167	[39030]	[39203]	['The mortality analyses were post hoc rather than a primary hypothesis and we did not have enough data to fully examine the effects of the different supplements on mortality.']	hypothesis	INCOMPLETE_EVIDENCE	[39089]	[39099]	BMJ_2008_Nov_7_337_a2001_T52
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_167	[39030]	[39203]	['The mortality analyses were post hoc rather than a primary hypothesis and we did not have enough data to fully examine the effects of the different supplements on mortality.']	did not	INCOMPLETE_EVIDENCE	[39107]	[39114]	BMJ_2008_Nov_7_337_a2001_T53
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_167	[39030]	[39203]	['The mortality analyses were post hoc rather than a primary hypothesis and we did not have enough data to fully examine the effects of the different supplements on mortality.']	effects	SUPERFICIAL_RELATIONSHIP	[39153]	[39160]	BMJ_2008_Nov_7_337_a2001_T135
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_168	[39204]	[39358]	['For example, the non-significant reduction in neonatal mortality associated with multiple micronutrients might have been significant with a larger sample.']	associated	SUPERFICIAL_RELATIONSHIP	[39269]	[39279]	BMJ_2008_Nov_7_337_a2001_T136
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_168	[39204]	[39358]	['For example, the non-significant reduction in neonatal mortality associated with multiple micronutrients might have been significant with a larger sample.']	might	INCOMPLETE_EVIDENCE	[39309]	[39314]	BMJ_2008_Nov_7_337_a2001_T54
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_169	[39359]	[39550]	['The outcome data were collected by the local health service staff, although the research team did provide special training on how to measure and record these outcome indicators for the trial.']	although	ANOMALY_CURIOUS_FINDING	[39426]	[39434]	BMJ_2008_Nov_7_337_a2001_T189
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_169	[39359]	[39550]	['The outcome data were collected by the local health service staff, although the research team did provide special training on how to measure and record these outcome indicators for the trial.']	how	EXPLICIT_QUESTION	[39485]	[39488]	BMJ_2008_Nov_7_337_a2001_T4
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_170	[39551]	[39754]	['The balance of treatments by area and therefore by service providers reduced the likelihood of any systematic differences in misclassification of stillbirths and early neonatal deaths by treatment group.']	therefore	PROBABLE_UNDERSTANDING	[39589]	[39598]	BMJ_2008_Nov_7_337_a2001_T90
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_170	[39551]	[39754]	['The balance of treatments by area and therefore by service providers reduced the likelihood of any systematic differences in misclassification of stillbirths and early neonatal deaths by treatment group.']	likelihood	PROBABLE_UNDERSTANDING	[39632]	[39642]	BMJ_2008_Nov_7_337_a2001_T91
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_170	[39551]	[39754]	['The balance of treatments by area and therefore by service providers reduced the likelihood of any systematic differences in misclassification of stillbirths and early neonatal deaths by treatment group.']	misclassification	PROBLEM_COMPLICATION	[39676]	[39693]	BMJ_2008_Nov_7_337_a2001_T225
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	awareness	IMPORTANT_CONSIDERATION	[39879]	[39888]	BMJ_2008_Nov_7_337_a2001_T163
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	however	ALTERNATIVE_OPTIONS_CONTROVERSY	[39964]	[39971]	BMJ_2008_Nov_7_337_a2001_T216
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_172	[39864]	[40089]	['The heightened awareness and knowledge about reproduction because of the one child policy in China, however, might have improved the accuracy of the respondent’s recall of her last menstrual period and other perinatal events.']	might	INCOMPLETE_EVIDENCE	[39973]	[39978]	BMJ_2008_Nov_7_337_a2001_T55
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	explain	PROBABLE_UNDERSTANDING	[40141]	[40148]	BMJ_2008_Nov_7_337_a2001_T92
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	apparent	INCOMPLETE_EVIDENCE	[40153]	[40161]	BMJ_2008_Nov_7_337_a2001_T56
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	apparent	ANOMALY_CURIOUS_FINDING	[40153]	[40161]	BMJ_2008_Nov_7_337_a2001_T190
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	reported	INCOMPLETE_EVIDENCE	[40207]	[40215]	BMJ_2008_Nov_7_337_a2001_T57
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	other	INCOMPLETE_EVIDENCE	[40221]	[40226]	BMJ_2008_Nov_7_337_a2001_T58
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[40221]	[40226]	BMJ_2008_Nov_7_337_a2001_T217
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	associated	SUPERFICIAL_RELATIONSHIP	[40435]	[40445]	BMJ_2008_Nov_7_337_a2001_T137
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	23These findings	INCOMPLETE_EVIDENCE	[40777]	[40793]	BMJ_2008_Nov_7_337_a2001_T59
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	interpreted	INCOMPLETE_EVIDENCE	[40799]	[40810]	BMJ_2008_Nov_7_337_a2001_T60
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_173	[40091]	[40910]	['Comparison with other studies\nOur results help to explain the apparent increase in neonatal and perinatal mortality reported from other trials using the same or similar formulation of multiple micronutrient supplements compared with standard iron-folic acid supplements.212223In two trials from Nepal multiple micronutrient supplementation was associated with a non-significant increase in neonatal and perinatal mortality compared with iron-folic acid.2122In a pooled analysis of these trials neonatal mortality (relative risk 1.52, 1.03 to 2.25) and perinatal mortality (1.36, 1.02 to 1.81) were significantly higher in the multiple micronutrients group compared with iron-folic acid.23These findings were interpreted by the authors as an increased risk of perinatal mortality with multiple micronutrient supplements.']	as	PROBABLE_UNDERSTANDING	[40826]	[40828]	BMJ_2008_Nov_7_337_a2001_T93
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	Our findings	QUESTION_ANSWERED_BY_THIS_WORK	[40911]	[40923]	BMJ_2008_Nov_7_337_a2001_T234
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_174	[40911]	[41094]	['Our findings showed a significant reduction in neonatal mortality for iron-folic acid (47%) and a non-significant reduction for multiple micronutrients (39%) compared with folic acid.']	showed	INCOMPLETE_EVIDENCE	[40924]	[40930]	BMJ_2008_Nov_7_337_a2001_T61
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	effect	SUPERFICIAL_RELATIONSHIP	[41107]	[41113]	BMJ_2008_Nov_7_337_a2001_T138
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	could	INCOMPLETE_EVIDENCE	[41184]	[41189]	BMJ_2008_Nov_7_337_a2001_T62
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	account for	PROBABLE_UNDERSTANDING	[41190]	[41201]	BMJ_2008_Nov_7_337_a2001_T94
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	why	EXPLICIT_QUESTION	[41202]	[41205]	BMJ_2008_Nov_7_337_a2001_T5
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	appearance	ANOMALY_CURIOUS_FINDING	[41275]	[41285]	BMJ_2008_Nov_7_337_a2001_T191
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_175	[41095]	[41329]	['The greater effect on mortality of iron-folic acid compared with multiple micronutrients could account for why comparisons of multiple micronutrients with iron-folic acid give the appearance of an increased risk of neonatal mortality.']	increased risk	IMPORTANT_CONSIDERATION	[41292]	[41306]	BMJ_2008_Nov_7_337_a2001_T164
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	similarities	INCOMPLETE_EVIDENCE	[41340]	[41352]	BMJ_2008_Nov_7_337_a2001_T63
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[41392]	[41397]	BMJ_2008_Nov_7_337_a2001_T218
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	impact	SUPERFICIAL_RELATIONSHIP	[41531]	[41537]	BMJ_2008_Nov_7_337_a2001_T139
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_176	[41330]	[41873]	['There are similarities between our results and the results of other earlier controlled trials of iron supplementation in pregnancy.2425In Niger, a double blind randomised controlled trial assessed the impact of 100 mg iron or placebo in the third trimester on iron status of the mother and newborn and on the anthropometric status of the newborn.24The iron supplements were associated with significantly decreased maternal iron deficiency at delivery and at three months after delivery and increased the iron status of the infants at 3 months.']	associated	SUPERFICIAL_RELATIONSHIP	[41704]	[41714]	BMJ_2008_Nov_7_337_a2001_T140
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	findings	INCOMPLETE_EVIDENCE	[42405]	[42413]	BMJ_2008_Nov_7_337_a2001_T64
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	consistent	INCOMPLETE_EVIDENCE	[42424]	[42434]	BMJ_2008_Nov_7_337_a2001_T65
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	observational	INCOMPLETE_EVIDENCE	[42451]	[42464]	BMJ_2008_Nov_7_337_a2001_T66
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	reported	INCOMPLETE_EVIDENCE	[42478]	[42486]	BMJ_2008_Nov_7_337_a2001_T67
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	increased risk	IMPORTANT_CONSIDERATION	[42490]	[42504]	BMJ_2008_Nov_7_337_a2001_T165
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	showed	INCOMPLETE_EVIDENCE	[42666]	[42672]	BMJ_2008_Nov_7_337_a2001_T68
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	complex	DIFFICULT_TASK	[42953]	[42960]	BMJ_2008_Nov_7_337_a2001_T2
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	31In	INCOMPLETE_EVIDENCE	[43131]	[43135]	BMJ_2008_Nov_7_337_a2001_T69
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	trial	QUESTION_ANSWERED_BY_THIS_WORK	[43140]	[43145]	BMJ_2008_Nov_7_337_a2001_T235
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	even	ANOMALY_CURIOUS_FINDING	[43147]	[43151]	BMJ_2008_Nov_7_337_a2001_T192
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	though	ANOMALY_CURIOUS_FINDING	[43152]	[43158]	BMJ_2008_Nov_7_337_a2001_T193
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	led	SUPERFICIAL_RELATIONSHIP	[43306]	[43309]	BMJ_2008_Nov_7_337_a2001_T141
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_179	[42105]	[43379]	['In the US, a trial of iron supplementation (30 mg/day) versus placebo from 11 weeks’ gestation in pregnant women who were not anaemic reported a significantly longer duration of gestation (0.6 weeks) and fourfold reduction in the risk of preterm low birth weight in the iron supplemented women.25Our findings were also consistent with those from observational studies that reported an increased risk of preterm delivery in women with iron deficiency anaemia in the first trimester of pregnancy.2627282930For example, an analysis of perinatal data from Shanghai showed a greater than twofold increase in the risk of low birth weight and preterm delivery in women who had moderate anaemia (90-99 g/l) and a greater than threefold increase for women with severe anaemia (<90 g/l) in the first trimester.29\nThe absorption of iron during pregnancy is a complex physiological process, with increasing relative absorption as gestation progresses but with a decrease in the percentage of the dose absorbed as the total dose increases.31In our trial, even though the amount of iron in the iron-folic acid supplement was twice the amount in the multiple micronutrient supplement this would not necessarily have led to twice the absorption of iron and therefore twice the dose of iron.']	therefore	PROBABLE_UNDERSTANDING	[43346]	[43355]	BMJ_2008_Nov_7_337_a2001_T95
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	might	INCOMPLETE_EVIDENCE	[43436]	[43441]	BMJ_2008_Nov_7_337_a2001_T70
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_180	[43380]	[43567]	['The vitamin C in the multiple micronutrient supplements might have enhanced the absorption of iron and also contributed to reducing the difference in the absolute amount of iron absorbed.']	contributed to	SUPERFICIAL_RELATIONSHIP	[43488]	[43502]	BMJ_2008_Nov_7_337_a2001_T142
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	similar	SUPERFICIAL_RELATIONSHIP	[43665]	[43672]	BMJ_2008_Nov_7_337_a2001_T143
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	but	ANOMALY_CURIOUS_FINDING	[43674]	[43677]	BMJ_2008_Nov_7_337_a2001_T194
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	associated	SUPERFICIAL_RELATIONSHIP	[43682]	[43692]	BMJ_2008_Nov_7_337_a2001_T144
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	seemed to be	ANOMALY_CURIOUS_FINDING	[43712]	[43724]	BMJ_2008_Nov_7_337_a2001_T195
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_181	[43568]	[43806]	['The response of haemoglobin concentration to the iron-folic acid and multiple micronutrients was similar, but the associated neonatal mortality seemed to be proportionate to the likely relative amount of iron contained in each supplement.']	likely	PROBABLE_UNDERSTANDING	[43746]	[43752]	BMJ_2008_Nov_7_337_a2001_T96
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	finding	INCOMPLETE_EVIDENCE	[43927]	[43934]	BMJ_2008_Nov_7_337_a2001_T71
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	similar to	INCOMPLETE_EVIDENCE	[43939]	[43949]	BMJ_2008_Nov_7_337_a2001_T72
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	observed	INCOMPLETE_EVIDENCE	[43955]	[43963]	BMJ_2008_Nov_7_337_a2001_T73
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	less	INCOMPLETE_EVIDENCE	[44151]	[44155]	BMJ_2008_Nov_7_337_a2001_T74
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	reported	INCOMPLETE_EVIDENCE	[44166]	[44174]	BMJ_2008_Nov_7_337_a2001_T75
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[44178]	[44183]	BMJ_2008_Nov_7_337_a2001_T219
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	other studies	INCOMPLETE_EVIDENCE	[44178]	[44191]	BMJ_2008_Nov_7_337_a2001_T76
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	did not	INCOMPLETE_EVIDENCE	[44203]	[44210]	BMJ_2008_Nov_7_337_a2001_T77
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	although	ANOMALY_CURIOUS_FINDING	[44252]	[44260]	BMJ_2008_Nov_7_337_a2001_T196
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	might	INCOMPLETE_EVIDENCE	[44317]	[44322]	BMJ_2008_Nov_7_337_a2001_T78
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_183	[43922]	[44461]	['This finding was similar to that observed in other trials comparing iron-folic acid and multiple micronutrients, but the total increase in birth weight in our multiple micronutrients group compared with iron-folic acid group was less than that reported in other studies.223233This did not translate into lower neonatal mortality, although it implies improved fetal growth and development, which might confer other health benefits to the newborn, such as improved infant growth, boosted immune responses, and enhanced cognitive development.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[44330]	[44335]	BMJ_2008_Nov_7_337_a2001_T220
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	have shown	INCOMPLETE_EVIDENCE	[44465]	[44475]	BMJ_2008_Nov_7_337_a2001_T79
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	important	IMPORTANT_CONSIDERATION	[44512]	[44521]	BMJ_2008_Nov_7_337_a2001_T166
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	effects	SUPERFICIAL_RELATIONSHIP	[44529]	[44536]	BMJ_2008_Nov_7_337_a2001_T145
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	potential	INCOMPLETE_EVIDENCE	[44568]	[44577]	BMJ_2008_Nov_7_337_a2001_T80
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_184	[44462]	[44695]	['We have shown that micronutrient supplements have important health effects for the newborn infant, with a potential to increase birth weight and birth length through increased duration of gestation and direct effects on fetal growth.']	effects	SUPERFICIAL_RELATIONSHIP	[44671]	[44678]	BMJ_2008_Nov_7_337_a2001_T146
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	seems to be	ANOMALY_CURIOUS_FINDING	[44723]	[44734]	BMJ_2008_Nov_7_337_a2001_T197
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	possibly	INCOMPLETE_EVIDENCE	[44778]	[44786]	BMJ_2008_Nov_7_337_a2001_T81
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_185	[44696]	[44867]	['Reduced neonatal mortality seems to be a response to the iron in the supplements, possibly mediated by increased duration of gestation and lower rates of preterm delivery.']	mediated	SUPERFICIAL_RELATIONSHIP	[44787]	[44795]	BMJ_2008_Nov_7_337_a2001_T147
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	recommend	FUTURE_WORK	[44878]	[44887]	BMJ_2008_Nov_7_337_a2001_T152
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	proposed	INCOMPLETE_EVIDENCE	[44934]	[44942]	BMJ_2008_Nov_7_337_a2001_T82
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_186	[44868]	[45164]	['We cannot recommend that multiple micronutrients at the currently proposed dose12should replace standard iron-folic acid supplements in pregnancy because they seem to provide less protection against preterm delivery and neonatal deaths in populations where iron deficiency in pregnancy is common.']	seem	ANOMALY_CURIOUS_FINDING	[45027]	[45031]	BMJ_2008_Nov_7_337_a2001_T198
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_187	[45165]	[45319]	['An adequate dose of iron is required in micronutrient supplements for pregnant women in developing countries to maximise reductions in neonatal mortality.']	required	IMPORTANT_CONSIDERATION	[45193]	[45201]	BMJ_2008_Nov_7_337_a2001_T167
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	remain	INCOMPLETE_EVIDENCE	[45373]	[45379]	BMJ_2008_Nov_7_337_a2001_T83
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	major cause	IMPORTANT_CONSIDERATION	[45382]	[45393]	BMJ_2008_Nov_7_337_a2001_T168
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	associated	SUPERFICIAL_RELATIONSHIP	[45467]	[45477]	BMJ_2008_Nov_7_337_a2001_T148
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	major	IMPORTANT_CONSIDERATION	[45511]	[45516]	BMJ_2008_Nov_7_337_a2001_T169
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	poor	IMPORTANT_CONSIDERATION	[45575]	[45579]	BMJ_2008_Nov_7_337_a2001_T170
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	this study	QUESTION_ANSWERED_BY_THIS_WORK	[45647]	[45657]	BMJ_2008_Nov_7_337_a2001_T236
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	associated	SUPERFICIAL_RELATIONSHIP	[45765]	[45775]	BMJ_2008_Nov_7_337_a2001_T149
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	but	ANOMALY_CURIOUS_FINDING	[45954]	[45957]	BMJ_2008_Nov_7_337_a2001_T199
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	despite	ANOMALY_CURIOUS_FINDING	[45959]	[45966]	BMJ_2008_Nov_7_337_a2001_T200
BMJ_2008_Nov_7_337_a2001	BMJ_2008_Nov_7_337_a2001_188	[45321]	[46212]	['What is already known on this topic\nNeonatal deaths remain a major cause of child mortality in those aged under 5 in developing countries and are associated with low birth weight\nOne of the major causes of low birth weight in developing countries is the poor nutritional status of the mother before and during pregnancy\n\nWhat this study adds\nAntenatal iron-folic acid increases the duration of gestation, reduces early preterm delivery, and is associated with a significant reduction in early neonatal mortality compared with folic acid alone\nAntenatal multiple micronutrients modestly increase birth weight compared with folic acid but, despite this weight gain, are not associated with reduced early neonatal mortality\nAn adequate dose of iron is required in micronutrient supplements for pregnant women to maximise reductions in neonatal mortality in developing countries\n\nPubMed Central:']	required	IMPORTANT_CONSIDERATION	[46070]	[46078]	BMJ_2008_Nov_7_337_a2001_T171
